M&A Deal Summary |
|
|---|---|
| Date | 2017-03-31 |
| Target | Dynex Technologies |
| Sector | Medical Products |
| Buyer(s) | Telegraph Hill Partners |
| Sellers(s) | Ampersand Capital Partners |
| Deal Type | Secondary Buyout |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Venture Capital Firm |
|---|---|
| Founded | 2001 |
| Size | Middle-Market |
| Type | Sector Focused |
Telegraph Hill Partners is a specialist private equity firm focused on investing in later-stage life science, medical device, and healthcare companies. Prospective companies should be at or near profitability and demonstrate success. Other areas of interest within the healthcare sector include life science technologies, chemistry/reagent suppliers, and information management. Telegraph Hill Partners was formed in 2001 and is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 24 of 33 |
| Sector (Medical Products) | 13 of 17 |
| Type (Secondary Buyout) | 1 of 1 |
| State (Virginia) | 1 of 1 |
| Country (United States) | 21 of 30 |
| Year (2017) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-10-15 |
TrakCel
Cardiff, United Kingdom TrakCel is a provider of cellular orchestration technology to aid in the delivery of regenerative therapies. TrakCel's cell, gene, and immunotherapy management solution improves clinical study efficacy and accelerates global scale-up and scale-out by implementing communications technology to integrate the delivery path from needle-to-needle. TrakCel was founded in 2012 and is based in Cardiff, United Kingdom. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-08-24 |
Verogen
San Diego, California, United States Verogen is a developer, manufacturer, and sells forensic genomics products and services, including for next-generation sequencing. Verogen was formed in 2017 and is based in San Diego, California. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 32 of 55 |
| Sector (Medical Products) | 10 of 14 |
| Type (Secondary Buyout) | 3 of 6 |
| State (Virginia) | 1 of 1 |
| Country (United States) | 32 of 51 |
| Year (2017) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-03-07 |
Genoptix
Carlsbad, California, United States Genoptix, Inc. is one of the largest hematopathology testing laboratories in the U.S., providing thousands of oncologists and pathologists across the United States with comprehensive testing solutions in hematology and solid tumor molecular profiling. Genoptix, Inc. was founded in 1999 and is based in Carlsbad, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-08-10 |
Roadrunner Pharmacy
Phoenix, Arizona, United States Roadrunner Pharmacy, Inc. is a provider of technology-enabled healthcare services for companion and equine veterinary practitioners. Roadrunner Pharmacy, Inc. was established in 1999 and is based in Phoenix, Arizona. |
Sell | - |
